Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment

Cell(2021)10.1016/j.cell.2021.02.055Source: DataRank Database

The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment is a research paper published in Cell (2021). On theSindex it has a DataRank of 0.790. It has been cited 193 times.

N/A

0.790DataRank · unranked

Scored on demand from live citation data

Open Access193 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 11.66)OA: bronzeTopics (41)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.790

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (5)

Jean C. Zenklusen ORCID,Louis M. Staudt ORCID,James H. Doroshow ORCID,Douglas R. Lowy ORCID,Henry Rodriguez ORCID

Live enrichment

PubMed:33798439 PMC:PMC8459793 OpenAlex:https://openalex.org/W3151381390

Intramural NIH HHS

Grant: Z99 CA999999

FWCI

11.66

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttp://www.cell.com/article/S0092867421002853/pdf

publisherhttp://www.cell.com/article/S0092867421002853/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867421002853?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421002853?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2021.02.055

Fields of Study

Cancer Genomics and DiagnosticsAdvanced Proteomics Techniques and ApplicationsCancer Research and TreatmentsDatabases, GeneticDrug DiscoveryGenetic Association StudiesHumansNeoplasmsPrecision MedicineProteogenomics

MeSH Terms

ProteogenomicsHumansNeoplasmsDatabases, GeneticDrug DiscoveryGenetic Association StudiesPrecision Medicine

Keywords

ProteogenomicsPrecision oncologyBiologyPrecision medicineCancerCancer treatmentClinical trialClinical OncologyMedical physicsOncologyComputational biologyInternal medicineBioinformaticsGenomeGenomicsMedicineGeneticsProteomicsdata sharingTargeted TherapyCollaborationOpen AccessMolecular MedicineCancer Diagnosis

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of ForestSubtype: a cancer subtype identifying approach based on high-dimensional genomic data and a parallel random forest

10.6084/m9.figshare.23714244.v1figshare

Additional file 1 of ForestSubtype: a cancer subtype identifying approach based on high-dimensional genomic data and a parallel random forest

10.6084/m9.figshare.23714244figshare